Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Esai"

44 News Found

Hester Biosciences appoints Ashish Desai as CFO
People | November 23, 2025

Hester Biosciences appoints Ashish Desai as CFO

Desai is currently serving the company as Group Finance Controller


Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
interviews | September 05, 2022

Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries

We are launching the five new products in the new manufacturing facility and they're all pharmaceuticals and this should lead to an increase in pharma numbers.


Experts call for easing access to 2mg and 4mg nicotine replacement therapies
Public Health | May 07, 2026

Experts call for easing access to 2mg and 4mg nicotine replacement therapies

With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical


HOSMAC enables first phase of 1,200-bed Tapanbhai Patel Memorial Hospital in Shirpur
Hospitals | May 04, 2026

HOSMAC enables first phase of 1,200-bed Tapanbhai Patel Memorial Hospital in Shirpur

Hospital project inaugurated by Devendra Fadnavis aims to strengthen healthcare access across North Maharashtra and nearby regions


India’s Biotech Moment: Eyestem CEO bets on fast-tracked cures & global breakthroughs
Biotech | April 16, 2026

India’s Biotech Moment: Eyestem CEO bets on fast-tracked cures & global breakthroughs

Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments


MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price
Drug Approval | April 15, 2026

MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price

CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing


Eyestem moves closer to blindness breakthrough with phase 2 trial green light
R&D | January 29, 2026

Eyestem moves closer to blindness breakthrough with phase 2 trial green light

The early-stage trial demonstrated an excellent safety profile alongside clinically meaningful improvements in visual acuity


Remedium Lifecare is now Supha Pharmachem
News | December 17, 2025

Remedium Lifecare is now Supha Pharmachem

The company shall process the change of name application with BSE Ltd. in due course


India’s pharma industry showcases innovation, global ambitions at CPHI & PMEC India 2025
News | November 27, 2025

India’s pharma industry showcases innovation, global ambitions at CPHI & PMEC India 2025

India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem